Scrutiny plans for high-risk devices in EU face dilution
This article was originally published in SRA
The Council of the EU is recommending that the scope of high-risk medical devices, which would be subject to the European Commission’s proposed “scrutiny procedure” under the new Medical Device Regulation, be substantially whittled down to include Class III implantables only, and not all Class III devices1.
You may also be interested in...
While the UK is moving forward quickly to provide COVID-19 antibody self-testing, the Belgian government considers the tests not sufficiently accurate to be used in the pandemic.
Following hot on the heels of its Rapidly Manufactured Ventilator Specification document, the UK’s regulator has issued another speedy regulatory permit for fast production of respiratory assist devices.
The UK is taking measures to increase its ventilator stock from 8,000 to some 30,000, but it will take time to make them available. Many are asking whether the government really rejected EU help, which could have brought relief sooner, because of Brexit.